ImmunityBio (IBRX) Net Margin Growth (5y) (2019 - 2026)
ImmunityBio (IBRX) Net Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.19 Bn | 6.81 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.65 Mn |
| Dec 31, 2025 | 32.64 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 2.19 Mn |
| Dec 31, 2024 | 122.15 Mn |
| Sep 30, 2024 | 12.84 Mn |
| Jun 30, 2024 | 8.53 Mn |
| Mar 31, 2024 | 2.24 Mn |
| Dec 31, 2023 | -126.91 Mn |
| Sep 30, 2023 | -4.04 Mn |
| Jun 30, 2023 | 35.62 Mn |
| Mar 31, 2023 | 51.80 Mn |
| Dec 31, 2022 | 5.57 Mn |
| Sep 30, 2022 | 20.54 Mn |
| Jun 30, 2022 | -10.34 Mn |
| Mar 31, 2022 | -51.28 Mn |
| Dec 31, 2021 | -69.85 Mn |
| Sep 30, 2021 | 13.18 Mn |
| Jun 30, 2021 | 25.69 Mn |